18F-FDG uptake assessed by PET/CT in abdominal aortic aneurysms is associated with cellular and molecular alterations prefacing wall deterioration and rupture

Journal of Nuclear Medicine

Volumn 54, Issue 10, 2013, Pages 1740-1747

  Courtois, Audrey ^a   Nusgens, Betty V ^a   Hustinx, Roland ^b   Namur, Gauthier ^b   Gomez, Pierre ^c   Somja, Joan ^b   Defraigne, Jean Olivier ^b   Delvenne, Philippe ^b   Michel, Jean Baptiste ^d   Colige, Alain C ^a   Sakalihasan, Natzi ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c Department of Nuclear Medicine CHC St Joseph ^*  (Belgium)

^d INSERM   (France)

Author keywords

Aneurysm; Inflammation; Metalloproteinases; Positron emission tomography; Rupture

Indexed keywords

C REACTIVE PROTEIN; COLLAGENASE 3; FLUORODEOXYGLUCOSE F 18; INTERSTITIAL COLLAGENASE; BIOLOGICAL MARKER; GELATINASE A; GELATINASE B; DIAGNOSTIC AGENT; METALLOPROTEINASE;

ABDOMINAL AORTA ANEURYSM; AGED; AORTA WALL; ARTICLE; BLOOD VESSEL BIOPSY; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; ZYMOGRAPHY; ABDOMINAL AORTA; AORTA RUPTURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; IMMUNOLOGY; LEUKOCYTE; METABOLISM; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SCINTISCANNING; TRANSPORT AT THE CELLULAR LEVEL; VERY ELDERLY; ANEURYSM; INFLAMMATION; RUPTURE;

AGED; AGED, 80 AND OVER; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; AORTIC RUPTURE; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT; ENZYME ACTIVATION; FEMALE; FLUORODEOXYGLUCOSE F18; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

ANEURYSM; INFLAMMATION; METALLOPROTEINASES; POSITRON EMISSION TOMOGRAPHY; RUPTURE;

EID: 84891693573     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.115873     Document Type: Article

References (33)

1. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005;365:1577-1589.
2. Limet R, Sakalihassan N, Albert A. Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J Vasc Surg. 1991;14: 540-548.
3. Kurvers H, Veith FJ, Lipsitz EC, et al. Discontinuous, staccato growth of abdominal aortic aneurysms. J Am Coll Surg. 2004;199:709-715.
4. Powell JT, Gotensparre SM, Sweeting MJ, Brown LC, Fowkes FG, Thompson SG. Rupture rates of small abdominal aortic aneurysms: a systematic review of the literature. Eur J Vasc Endovasc Surg. 2011;41:2-10.
5. Georgakarakos E, Ioannou CV. Geometrical factors as predictors of increased growth rate or increased rupture risk in small aortic aneurysms. Med Hypotheses. 2012;79:71-73.
6. Michel JB, Thaunat O, Houard X, Meilhac O, Caligiuri G, Nicoletti A. Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol. 2007;27:1259-1268.
7. Sakalihasan N, Delvenne P, Nusgens BV, Limet R, Lapiere CM. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg. 1996;24: 127-133.
8. Liapis CD, Paraskevas KI. The pivotal role of matrix metalloproteinases in the development of human abdominal aortic aneurysms. Vasc Med. 2003;8:267-271.
9. Sakalihasan N, Heyeres A, Nusgens BV, Limet R, Lapiere CM. Modifications of the extracellular matrix of aneurysmal abdominal aortas as a function of their size. Eur J Vasc Surg. 1993;7:633-637.
10. Petersen E, Wagberg F, Angquist KA. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture. Eur J Vasc Endovasc Surg. 2002;23:153-157.
11. Wilson WR, Anderton M, Schwalbe EC, et al. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture. Circulation. 2006; 113:438-445.
12. Defawe OD, Colige A, Lambert CA, et al. Gradient of proteolytic enzymes, their inhibitors and matrix proteins expression in a ruptured abdominal aortic aneurysm. Eur J Clin Invest. 2004;34:513-514.
13. Sakalihasan N, Michel JB. Functional imaging of atherosclerosis to advance vascular biology. Eur J Vasc Endovasc Surg. 2009;37:728-734.
14. Rudd JH, Hyafil F, Fayad ZA. Inflammation imaging in atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1009-1016.
15. Sakalihasan N, Van Damme H, Gomez P, et al. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg. 2002;23:431-436.
16. Sakalihasan N, Hustinx R, Limet R. Contribution of PET scanning to the evaluation of abdominal aortic aneurysm. Semin Vasc Surg. 2004;17:144-153.
17. Defawe OD, Hustinx R, Defraigne JO, Limet R, Sakalihasan N. Distribution of F-18 fluorodeoxyglucose (F-18 FDG) in abdominal aortic aneurysm: high accumulation in macrophages seen on PET imaging and immunohistology. Clin Nucl Med. 2005;30:340-341.
18. 18Ffluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg. 2008;48:417-423.
19. 18F-FDG PET/CT. J Nucl Med. 2007;48:1053-1059.
20. 18FFDG: standardized uptake values in normal tissues. J Nucl Med. 2004;45: 784-788.
21. Reeps C, Bundschuh RA, Pellisek J, et al. Quantitative assessment of glucose metabolism in the vessel wall of abdominal aortic aneurysms: correlation with histology and role of partial volume correction. Int J Cardiovasc Imaging. 2013; 29:505-512.
22. 18F-FDG uptake in aortic aneurysm wall are associated with high wall stress. Eur J Vasc Endovasc Surg. 2010;39:295-301.
23. Ocana E, Bohorquez JC, Perez-Requena J, Brieva JA, Rodriguez C. Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis. 2003;170:39-48.
24. van de Pavert SA, Mebius RE. New insights into the development of lymphoid tissues. Nat Rev Immunol. 2010;10:664-674.
25. Gräbner R, Lotzer K, Dopping S, et al. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J Exp Med. 2009;206:233-248.
26. Manzo A, Paoletti S, Carulli M, et al. Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol. 2005;35:1347-1359.
27. Wang Y, Ait-Oufella H, Herbin O, et al. TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin IIinfused mice. J Clin Invest. 2010;120:422-432.
28. Dai J, Losy F, Guinault AM, et al. Overexpression of transforming growth factorbeta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy. Circulation. 2005;112: 1008-1015.
29. Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J, Libby P. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation. 1999;99:96-104.
30. Leeman MF, Curran S, Murray GI. The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol. 2002;37:149-166.
31. Reeps C, Pelisek J, Seidl S, et al. Inflammatory infiltrates and neovessels are relevant sources of MMPs in abdominal aortic aneurysm wall. Pathobiology. 2009;76:243-252.
32. Domanovits H, Schillinger M, Mullner M, et al. Acute phase reactants in patients with abdominal aortic aneurysm. Atherosclerosis. 2002;163:297-302.
33. De Haro J, Acin F, Bleda S, Varela C, Medina FJ, Esparza L. Prediction of asymptomatic abdominal aortic aneurysm expansion by means of rate of variation of C-reactive protein plasma levels. J Vasc Surg. 2012;56:45-52.